Jean-Nicolas-Schickel

Jean-Nicolas joined Granite Bio in March 2024 as Director of Immunology. Jean-Nicolas has over 10 years' experience in leading pre-clinical immunology projects, both in inflammation and immuno-oncology fields. His experience spans from big pharma (Sanofi) to a contract research organisation (Evotec) and to biotech (Adimab, Vector). Prior to joining Granite Bio, he served as Director of Cancer Immunotherapy at Vector Biopharma. Jean-Nicolas received his PhD in cellular immunology from the University of Strasbourg and then moved to Yale for his postdoc in the group of Eric Meffre. He is also a member of the French Society of Immunology.